Convenient synthesis of diaryliodonium salts for the production of [18F]F-DOPA by Edwards, Richard et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/68275/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Edwards, Richard, Westwell, Andrew D., Daniels, Stephen and Wirth, Thomas 2015. Convenient
synthesis of diaryliodonium salts for the production of [18F]F-DOPA. European Journal of Organic
Chemistry 2015 (3) , pp. 625-630. 10.1002/ejoc.201403378 file 
Publishers page: http://dx.doi.org/10.1002/ejoc.201403378
<http://dx.doi.org/10.1002/ejoc.201403378>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
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of [18F]F-DOPA 
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[18F]F-DOPA is an important radiotracer that is used in the diagnosis 
of Parkinson’s disease and neuroendocrine tu-mours. We describe a 
simple synthesis for a number of diaryl-iodonium salt precursors that 
are suitable for the production of [18F]F-DOPA through reaction with 
no carrier added (n.c.a.) nucleophilic [18F]fluoride. The simple 
procedure gives bench-stable, complex iodonium precursors in good 
 
yields without the need for laborious anhydrous conditions. Further 
alteration to the precursor counterion can be readily achieved for a 
range of halides and pseudo halides by a sim-ple modification of the 
workup. Preliminary “hot” and “cold” fluorination results show the 
suitability of the compounds for the production of [18F]F-DOPA. 
 
 
 
Introduction 
 
The synthesis of radiolabelled compounds is currently an 
area of great interest, primarily due to their application in 
positron emission tomography (PET). This highly sensitive and 
versatile imaging technique allows for the pharmacoki-netic 
and biodistribution of positron emitters to be studied in vivo, 
and is crucial to diagnosis and evaluation of dis-eases, 
including cancers[1] and neurodegenerative diseases such as 
Parkinson’s disease.[2] 
 
[18F]Fluorine is a commonly used radioisotope in the 
production of such radiotracers. This popularity is due to a 
number of advantages; it has a relatively long half-life (109.8 
min) compared with that of 11C (20.4 min) and 13N (9.98 min), 
allowing multistep reactions, complex purifica-tions, and even 
transportation before unacceptable loss of radioactivity. In 
addition, it is also possible to produce [18F]fluorine in multi-
Curie levels with low energy.[3] The strength of the carbon–
fluorine bond means that such com-pounds generally show 
good metabolic stability in vivo. This is especially true of aryl 
carbon–fluorine bonds, with some aliphatic carbon–fluorine 
bonds being prone to enzy-matic cleavage.[4] 
 
Numerous methods exist for the incorporation of fluor-ine 
into molecules at an aryl position with both electro-philic and 
nucleophilic reagents. Nucleophilic incorporation of 
[18F]fluoride is the preferred route because of the high 
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specific activity (SA) of no carrier added (n.c.a.) [18F]fluor-
ide. Traditional nucleophilic routes for labelling aromatic 
compounds with [18F]fluoride include Balz–Schiemann and 
Wallach reactions.[5] Unfortunately, these transformations use 
harsh conditions and suffer from poor radiochemical yields 
(RCYs) and a narrow substrate scope. Aromatic nu-cleophilic 
substitution of halides and other leaving groups (notably NO2 
and N+Me3) can be used but, in general, these reactions are 
limited to aromatic compounds bearing electron-withdrawing 
groups and regioselectivity remains a significant issue. With 
these limitations, extending such methodologies to complex 
systems can be difficult and often requires multistep synthesis. 
 
For more electron-rich aryl moieties, the use of electro-
philic fluorine is traditionally more common, utilising [18F]-
fluorine gas or reagents produced from this source of the 18F 
nuclide. However, these methods are avoided if possible 
because of their numerous disadvantages including low SA and 
generally poor RCYs. The use of fluorine gas as the source of 
radioactivity also suffers from handling difficult-ies and a 
much reduced availability compared with that of n.c.a. 
[18F]fluoride. 
 
Recently, iodonium salts have generated much interest as 
precursors for the nucleophilic incorporation of [18F]fluor-ide 
into electron-rich target molecules. The properties of di-
aryliodonium salts make them ideal precursors for aromatic 
radiotracer synthesis using nucleophilic fluorination. A quick, 
selective reaction is crucial for short reaction and purification 
times to increase RCY. This is achieved by the high reactivity 
of the salts, which is attributed to the “hy-perleaving group 
ability” of the PhI group, being approxi-mately 106 times that 
of a triflate.[6] 
The use of diaryliodonium salts for the formation of [18F]-
labelled aromatic compounds was first reported by Pike et al. 
using both symmetrical and unsymmetrical di- 
 
 
  
  
   
aryliodonium precursors.[7] When an unsymmetrical diaryl- production facilities. An effective [18F]F-DOPA synthesis 
iodonium salt is used, the aromatic substituent at which the using a nucleophilic approach would provide a significant 
fluorination takes place is dependent on both the electronic improvement to the above synthesis, allowing a more ac- 
and steric properties of the two attached aryl moieties. This cessible and facile route to this vital radiopharmaceutical. 
allows precursors to be designed for selective fluorination Recent studies have led to vast improvements in nucleo- 
at the desired aromatic position by employing a small, elec- philic methodology for the synthesis of electron-rich aro- 
tron-rich aryl group (commonly 2-thienyl and 4-meth- matics such as [18F]F-DOPA. Ritter et al. recently reported 
oxyphenyl) as the “non-participating” aryl ring or other the production of protected [18F]F-DOPA and other radio- 
non-participating groups such as a [2,2]paracyclophane labelled targets by using a nickel complex in the presence 
moiety.[8] The application of spirocyclic iodonium ylide pre- of an oxidant.[12] Scott et al. found that copper-catalysed 
cursors for such a regioselective fluorination has also been radiofluorination of mesityl iodonium salts could be used 
reported to be of great efficacy by Liang et al.[9] to access protected [18F]F-DOPA.[13] Gouverneur et al. have 
The employment of a diaryliodonium salt precursor for recently shown the utility of boronic esters as precursors for 
the synthesis of a practical PET tracer was first reported by nucleophilic [18F]fluorination also in the presence of a cop- 
Suzuki et al. for the synthesis of [18F]DAA1106, a tracer per catalyst.[14] This method allows access to high SA elec- 
used for imaging peripheral-type benzodiazepine receptor tron-rich targets including [18F]F-DOPA. 
in the brain.[10] The utility of such diaryliodonium salt pre- Drawbacks to these advancements in nucleophilic [18F]- 
cursors offers a selective and widely applicable methodol- fluorination include the use of metals in all cases and the 
ogy for  the introduction of  [18F]fluoride into  a large employment of air-sensitive reagents in those reported by 
number of functionalised arenes. Nevertheless, the use of Scott and Ritter. 
iodonium salts for the introduction of fluoride cannot be Herein, we report the synthesis of bench-stable diaryl- 
described as general, with a large range of fluorination con- iodonium salts that are suitable for the production of [18F]- 
ditions reported for a range of substrates. The production F-DOPA through reaction with n.c.a. nucleophilic [18F]- 
and fluorination of more complex biomedically relevant fluoride (Scheme 1b). Multiple strategies for salt formation 
iodonium precursors has until recently also been problem- are scrutinised, and preliminary “hot” and “cold” fluorina- 
atic. However, as the understanding and experience in this tion results are used to show the suitability of the molecules 
methodology grows, the use of iodonium salts as precursors for the production of [18F]F-DOPA. 
to form more complex, electron-rich radiotracers have seen  
much recent success.[11] 
Results and Discussion [18F]F-DOPA is a widely used radiotracer most com- 
monly employed in the diagnosis of Parkinson’s disease and 
Iodonium Precursor Formation Using Stannylated Protected 
neuroendocrine tumours (NETs).[1a,2a] The commonly used 
L-DOPA Ethyl Ester 
current synthesis of [18F]F-DOPA (Scheme 1a) proceeds 
 
through electrophilic destannylation with [18F]F2  gas. As The  reaction  of  hypervalent  iodine(III)  reagents  of 
expected, the reaction suffers from the disadvantages men- Koser-type  [ArI(OH)OTs]  with  arylstannanes  to  form 
tioned above and proceeds with poor RCYs, low SA, and iodonium tosylates is well known and provided the starting 
is unavailable to PET centres not equipped with [18F]F2 gas point for our investigation.[9]  The formation of 4-meth- 
  oxyphenyl- and 2-thienyl-substituted Koser-type reagents 
  was achieved by using reported methods (see the Support- 
  ing Information).[15] Alternatively, the reaction can be per- 
  formed with a Koser-type reagent produced in situ from its 
  corresponding diacetate. (Diacetoxyiodo)arenes were pro- 
  duced by using reported methods (see the Supporting Infor- 
  mation).[16]  The conditions tested for optimisation of the 
  salt formation are shown in Table 1. 
  The use of 2,2,2-trifluoroethanol (TFE) as solvent was 
  very detrimental to the reaction (Table 1, Entries 1 and 4) 
  despite being an excellent solvent for the formation of sim- 
  ple diaryliodonium salts.[17] However, when using a method 
  adapted from a procedure reported by Chun et al.,[18]  it 
  was found that the reaction proceeded well in a mixture of 
  chloroform and acetonitrile (Table 1, Entry 2). When ap- 
  proximately equimolar amounts of the hypervalent iodine 
  reagent 1 was used, it was found that a significant portion 
  of the stannane remained unreacted. 
  By  increasing  the  number  of  equivalents  (1.2  and 
  1.5 equiv.) of the Koser derivative, higher levels of conver- 
Scheme 1. Synthesis of [18F]F-DOPA. sion of stannane into the diaryliodonium salt was observed 
 
Diaryliodonium Salts for the Production of [18F]F-DOPA 
 
Table 1. Synthesis of diaryliodonium salts 4.[a] 
 
 
 
 
 
 
 
 
 
 
 
 
 
Entry Reagent Reagent [equiv.] Solvent Temperatue [°C] Yield of 4 [%] 
      
1 1a 1.02 CH2Cl2/TFE (1:1) 0 0 
2 1a 1.02 CHCl3/MeCN (5:1) reflux 24 
3 1a 1.2 CHCl3/MeCN (5:1) reflux 37 
4 1a 1.2 MeCN/CH2Cl2/TFE (1:2.5:2.5) reflux 0 
5 1a 1.5 CHCl3/MeCN (5:1) reflux 44 
6 2a 1.5 CHCl3/MeCN (5:1) reflux 24 
7 2b 1.2 CH2Cl2/MeCN (1:1) r.t. 26 
8 1b 1.2 CHCl3/MeCN (5:1) reflux 37 
9 1b 1.5 CHCl3/MeCN (5:1) 50 °C 60 
10 2b 1.5 CHCl3/MeCN (5:1) 50 °C 30 
 
[a] Reactions were carried out under ambient conditions; reaction time was 18 h. 
 
 
(Table 1, Entries 3 and 5). The addition of 1.5 equiv. of 1 was 
found to be optimal; the addition of larger amounts led to 
difficulties in purification. 
 
Interestingly, the reaction proceeded with higher yields 
when the stannane was reacted with the Koser reagent pro-
duced in situ (compound 1 and p-toluenesulfonic acid) rather 
than preformed Koser reagent (Table 1, Entries 5 vs. 6 and 9 
vs. 10). 
 
Conditions reported by Jang et al.[11a] were also investi-
gated, but the combination of dichloromethane and aceto-nitrile 
as solvent proved to be less fruitful than the op-timised 
conditions (Table 1, Entry 7). 
 
Under the optimised conditions the reaction proceeded with 
good yields for both 2-thienyl and 4-methoxyphenyl Koser 
reagents, with the highest yields being observed with the latter 
derivative (Table 1, Entries 5 and 9). 
 
Significant improvements to the product purity were ob-
served when the solution of the crude salt in dichlorometh-ane 
was washed with water before trituration. The use of the 
optimised reaction conditions for the formation of di-
aryliodonium salts with different protecting groups is shown in 
Table 2. 
 
The formation of diaryliodonium salts 4a and 7a pro-ceeded 
in reasonable yields (Table 2, Entries 1 and 2). Yields could be 
improved by increasing the number of equivalents of diacetate 
1 and p-toluenesulfonic acid. However, when the tetra-Boc-
protected stannyl precursor was treated with more than 1.5 
equiv. of p-toluenesulfonic acid, deprotection of one of the N-
Boc groups occurred to yield the tri-Boc-protected iodonium 
salt (4a). 
 
Surprisingly, reaction of the phthalimide-protected aryl-
stannane 6 with the 2-thienyl Koser reagent produced in situ 
proceeded very poorly, and a pure product could not 
 
 
Table 2. Synthesis of diaryliodonium salts with different nitrogen 
protections and counterions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Entry Ar R9 R99 Yield [%] 
     
1 4a(OTs) NHBoc Et 44 
2 7a(OTs) NBoc2 Et 28 
3 8a(OTs) NPhth Me 0 
4 4b(OTs) NHBoc Et 60 
5 7b(OTs) NBoc2 Et 26 
6 8b(OTs) NPhth Me 29 
     
 
be isolated. However, the reaction did proceed satisfactorily 
with the 4-methoxyphenyl Koser reagent produced in situ. The 
reasons for this unexpected change in reactivity are not clear at 
present. 
 
When the salt was washed with a saturated aqueous solu-
tion of a potassium salt then a simple counterion exchange 
 
  
 
    
   
occurred for salts including KI, KOTf and KBr. Yields for The formation of the fluorinated product was observed 
the counterion exchange to the iodonium bromide were in all reactions by 19F NMR and HPLC analyses, except for 
quantitative and performed for all compounds shown in the reaction performed in DMSO (Table 3, Entry 1). The 
Table 2. Conversion into the iodonium triflate was also formation of the iodonium fluoride intermediate 4(F) was 
quantitative, and conversion into the iodonium iodide pro- observed by 19F NMR spectroscopic analysis in all cases 
ceeded with 95 % yield. These counterion exchange pro- (see the Supporting Information). The thermal decomposi- 
cesses  were performed  with  compounds  4a(OTs) and tion of iodonium fluoride 4(F) in DMSO, however, did not 
4b(OTs).    proceed to give the fluorinated product (Table 3, Entry 1). 
It was found that conversion from the iodonium tosylate It should be noted that no production of 4-fluoroanisole or 
into the iodonium perchlorate could not be performed by 2-fluorothiophene was observed in any of these reactions. 
using this method but was achieved by using the procedure The reaction proceeds with both the thiophene- and the 
reported by Dinkelborg et al.[11c] Thus, the iodonium salt anisole-derived iodonium salts, with neither “non-partici- 
was charged on a reverse-phase C-18 cartridge before elut- pating” arene showing a clear advantage over the other, 
ing with an aqueous solution of perchloric acid through with all yields (determined by HPLC analysis) being be- 
the cartridge. Following this, water was passed through the tween 2 and 5 % (Table 3). 
cartridge before a gradient of acetonitrile and water was  
used to elute the iodonium perchlorate (see the Supporting 
“Hot” Fluorination Reactions Information).  
    After the success of the cold fluorinations, further inves- 
“Cold” Fluorination Reactions 
 tigation into the suitability of the precursors for production 
 of [18F]F-DOPA was carried out. Reactions were performed 
After the successful formation of different iodonium pre- 
with an automated Eckert & Ziegler system in a hot cell. 
Reaction of iodonium bromide 4b(Br) with azeotropically 
cursors, it was important to assess their suitability for the dried [18F]KF·Kryptofix 222·K2CO3 salt gave the 18F-lab- 
production of  F-DOPA.  Different  conditions  for the 
elled, protected DOPA compound 10 (Scheme 2). 
fluorination of iodonium salts have been reported.[19] We 
 
started our investigations by performing fluorinations using  
tetramethylammonium fluoride (TMAF) in a range of sol-  
vents. Acetonitrile, N,N-dimethylformamide DMF) and di-  
methyl  sulfoxide  (DMSO)  are  commonly  used  in  the  
fluorination of iodonium salts, and these were investigated  
first. Recent work by DiMagno et al. has shown that non-  
polar aprotic solvents such as benzene and toluene can also  
be used; they reported that thermal decomposition of the  
iodonium fluoride in such solvents can dramatically im- Scheme 2. Synthesis of hot [18F]F-DOPA. 
prove the fluorination yields.[20]  Therefore, fluorinations  
with TMAF were carried out in acetonitrile, DMF, DMSO Although the reaction proceeded with poor conversion 
and toluene, as shown in Table 3.  of [18F]fluoride into the labelled product, it was found that 
 
 
Table 3. Fluorinations of diaryliodonium salts 4 with TMAF. 
 
 
 
 
 
 
 
 
 
 
Entry Ar Fluorination solvent Yield [%][a] 
1 4b(Br) DMSO 0 
2 4b(Br) DMF 2 
3 4b(Br) MeCN 5 
4[b] 4b(Br) toluene 2 
5 4a(Br) MeCN 3 
6[b] 4a(Br) toluene 5 
[a] Yields were calculated based on HPLC analysis. [b] Iodonium fluoride 4a(F) was produced in acetonitrile before removal of the solvent. 
Compound 4a(F) was then redissolved in toluene and passed through a filter into a clean vessel for thermal decomposition to 9. 
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the reaction performed in a mixture of DMSO and aceto-  form (25 mL). The appropriate protected 6-(trimethylstannyl)-l- 
nitrile proceeded very cleanly. Interestingly, the reaction did  DOPA reagent (0.29 mmol) in chloroform (5 mL) was added drop- 
not proceed in DMSO alone, and reactions in either DMF  wise. The reaction mixture was heated to 50 °C and stirred for 18 h. 
or acetonitrile alone proceeded less cleanly, with the forma-  The reaction mixture was cooled to room temperature, and the 
 
solvent was removed under reduced pressure. The residue was dis- tion of a number of unidentified radiolabelled products. In  
 
solved in CH2Cl2 (40 mL) and washed with water/saturated KX (X 
all cases, the conversion of fluoride into any products was  
 
= Br, I, OTf) solution (3 3 40 mL). The organic layer was passed 
low, with , 1 % RCY.   
  through a phase separator and concentrated under reduced pres- 
Isolation  of  the  [18F]fluorinated  product  could  be 
 
 sure to give the crude product as a yellow oil. The product was 
achieved by using semipreparative HPLC purification to  triturated with hexane from a minimum amount of CH2Cl2 and 
give the product in . 95 % radiochemical purity.  diethyl ether (1:1). The precipitate was collected on a Telos phase 
Alternative protecting strategies for the amine showed no  separator and washed with hexane. The collected precipitate was 
advantages under the current conditions. No product for-  removed from the phase separator with CH2Cl2. The CH2Cl2 was 
mation was observed when using the iodonium bromide  removed before the product was triturated once more with hexane 
8b(Br) (phthalimide protected amine) as the precursor.  from a minimum amount of CH2Cl2 and diethyl ether (1:1). Re- 
 
moval of the solvent under reduced pressure gave the product as a Iodonium bromide 7b(Br) (di-Boc-protected amine) gave  
 
white solid.    
the corresponding 18F-labelled, protected DOPA moiety,     
 
General Procedure for No-Carrier-Added [18F]Fluoride Incorpora- but the reaction did not proceed cleanly.  
 
tion Using Iodonium Salts: [18F]Fluoride delivered from the cyclo- Decay-corrected RCYs were calculated by measurement  
 
tron as an aqueous solution was trapped on a pretreated QMA 
of the activity of the isolated [18F]labelled products in a  
 
cartridge to remove the 18O-enriched water. The [18F]fluoride was 
well counter, because conversions calculated from analytical  
 eluted with a Kryptofix 2.2.2 carbonate solution (0.6 mL) (0.3 mL 
HPLC proved to be inaccurate (see the Supporting Infor-  
 of MeCN, 0.3 mL of H2O, 22.8 mg of Kryptofix 2.2.2, 8.4 mg of 
mation). We would thus recommend caution when using  
 K2CO3) into a 5 mL V-shaped vial. The mixture was dried under 
HPLC analysis for monitoring the success of labelling reac-  a flow of nitrogen and reduced pressure at 120 °C for 440 s. 
tions.   The residue was azeotropically dried twice with the addition of 
To confirm the production of 18F-labelled, protected 
 acetonitrile (2 3 1 mL). Distillation was achieved by heating at 
DOPA in the successful reactions, the corresponding 19F  120 °C under a flow of nitrogen for 440 s. To the dried [18F]- 
compound was co-eluted during HPLC analysis. No chiral  KF·Kryptofix 222·K2CO3  salt were added iodonium precursor 
HPLC analysis has yet been performed to assess the chiral  (0.03 mmol) and TEMPO (0.021 mmol) in acetonitrile and DMSO 
 (1.5 mL) (2:1). The reaction mixture was heated at 90 °C for 30 min integrity of the product.   
  before being cooled to room temperature. The reaction mixture was 
   
   ejected into a sterile vial, and the activity was measured in a well 
Conclusions 
  counter to calculate the radiochemical recovery (RCR). The reac- 
  tion mixture was loaded onto the HPLC sample loop. Reverse- 
Different iodonium salt precursors for the synthesis of 
 phase purification was performed using a semipreparative Agilent 
 1200 column [4 mL/min, 70 % MeCN in H2O (0.01 % formic acid)]. 
[18F]F-DOPA have been synthesised in reasonable to good  
 The γ-peak was collected (retention time: 7.5–8.5 min), and the ac- 
yields by using a robust and facile route with no need for  tivity of the isolated product was measured with a Campitec CRC- 
laborious inert conditions. The complex iodonium precur-  25PET well counter. A 100 μL sample was taken for HPLC analysis 
sors are bench-stable molecules. Further exchange of the  to confirm the product as the protected [18F]F-DOPA.  
precursor counterion can be readily achieved with a range  Supporting Information (see footnote on the first page of this arti- 
of halides and pseudo halides by a simple alteration of the  cle): All synthetic methods including spectroscopic data and analyt- 
workup. The use of such precursors for the formation of  ical data.    
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